News & Publications

We are passing along information that may be of interest to some MCC patients and families… The Seattle MCC Support Group will host a special facilitated discussion on September 11 prior to the Nghiem Merkel Dinner Meeting. This discussion session is entitled: "GRIEF AND GRATTITUDE" SEPTE...

Objectives: CD200 expression has been well studied in hematopoietic malignancies; however, CD200 expression has not been well-characterized in neuroendocrine neoplasms. We examined CD200 expression in 391 neuroendocrine neoplasms from various anatomic sites. Methods: Tissue blocks containing pulmona...

https://www.usatoday.com/story/opinion/2017/08/06/clinical-trial-saved-my-life-could-save-yours-stan-collender-column/513055001/  

It was a few days after her son’s 6th birthday party four years ago when Carrie Best rolled over in bed and felt a pinch in her armpit. When she reached over and touched it, she jolted awake. Soon she'd learn that she had cancer. “I had a lump the size of a grape under my arm,” says Best, a 50...

In recognition of Dr. Gregg Schimmel's support of hundreds of Merkel cell patients around the country, the Dr. Gregg Schimmel Fund for Merkel Cell Carcinoma Research Fellows has been established. To learn more about Gregg and make a donation, please visit: supportuwmedicine.org/gregg-schimmel R...

Aim: This retrospective study of patients in the USA with metastatic Merkel cell carcinoma (mMCC) aimed to assess patient responses to second-line and later (2L+) and first-line (1L) chemotherapy. Patients & methods: Out of 686 patients with MCC identified in The US Oncology Network, 20 and 67 pati...

On June 9, 2017, Hutch news published Rose Wittman's Merkel cell carcinoma story as she failed to qualify for one clinical trial, but a later experimental treatment sent her into complete remission. To read more, view the article here. Furthermore, Fred Hutch has provided a medium for individual...

On May 31, 2017, Hutch News released an article highlighting the promising results from an ongoing early-stage trial. The combination of T-cell therapy, avelumab (the newly FDA- approved drug), followed by an immune booster has kept cancer from progressing in three out of four patients with metasta...

On May 9, 2017, Dermatology News published an article discussing the importance in conducting surveillance for recurrence in Merkel cell carcinoma. A two year retrospective cohort study conducted by Ms. Aubriana McEvoy and other colleagues, under the guidance of Dr. Paul Nghiem, has laid the foundat...

The 13th Congress of the European Association of Dermato-Oncology (EADO) was held in Athens, Greece on May 3-6, 2017 at the Megaron Athens International Conference Center. The event highlighted some of the major aspects of Merkel cell carcinoma, melanoma, and various other skin cancers. Dr. Nghiem ...